NeuroSense Therapeutics - 53 Year Dividend History | NRSN

Historical dividend payout and yield for NeuroSense Therapeutics (NRSN) since 1971. The current TTM dividend payout for NeuroSense Therapeutics (NRSN) as of December 11, 2024 is $0.00. The current dividend yield for NeuroSense Therapeutics as of December 11, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.012B $0.000B
NeuroSense Therapeutics Ltd. is a clinical-stage biotechnology company. It focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, such as ALS, Alzheimer's and Parkinson's disease. NeuroSense Therapeutics Ltd. is based in CAMBRIDGE, Mass.
Stock Name Country Market Cap PE Ratio